Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization
- 1 August 1994
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 76 (1) , 59-64
- https://doi.org/10.1016/0165-4608(94)90073-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemiaCancer Genetics and Cytogenetics, 1993
- The polymerase chain reaction: A new tool for the detection of minimal residual disease in haematological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991
- Review of clinical, cytogenetic, and molecular aspects of Ph-negative CMLCancer Genetics and Cytogenetics, 1991
- False-positive results with PCR to detect leukaemia-specific transcriptThe Lancet, 1990
- The Polymerase Chain ReactionNew England Journal of Medicine, 1990
- Detection of the Philadelphia chromosome in interphase nucleiCytogenetic and Genome Research, 1990
- Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemiaHuman Genetics, 1989
- MINIMAL RESIDUAL LEUKAEMIA IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER T-CELL DEPLETED BONE-MARROW TRANSPLANTATIONThe Lancet, 1989
- Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84Human Genetics, 1986
- A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemiaNature, 1982